Search

Your search keyword '"Pohlman, Brad"' showing total 1,080 results
Start Over Author "Pohlman, Brad"
1,080 results on '"Pohlman, Brad"'

151. Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era

Author

Starr, Adam G., primary, Caimi, Paolo F., additional, Fu, PingFu, additional, Massoud, Mira R., additional, Meyerson, Howard, additional, Hsi, Eric D., additional, Mansur, David B., additional, Cherian, Sheen, additional, Cooper, Brenda W., additional, De Lima, Marcos J. G., additional, Lazarus, Hillard M., additional, Gerson, Stanton L., additional, Jagadeesh, Deepa, additional, Smith, Mitchell R., additional, Dean, Robert M., additional, Pohlman, Brad L., additional, Hill, Brian T., additional, and William, Basem M., additional

Published
2016
Full Text
View/download PDF

152. Early stage, bulky Hodgkin lymphoma patients have a favorable outcome when treated with or without consolidative radiotherapy: potential role of PET scan in treatment planning

Author

Nguyen, Van T., primary, Pophali, Priyanka A., additional, Tsai, Judy P., additional, Jagadeesh, Deepa, additional, Dean, Robert M., additional, Pohlman, Brad, additional, Morgan, David S., additional, Greer, John P., additional, Smith, Mitchell R., additional, Hill, Brian T., additional, and Reddy, Nishitha M., additional

Published
2016
Full Text
View/download PDF

155. Evaluation of Ciprofloxacin in the Treatment of BK VIRUS-Associated Hemorrhagic Cystitis in Hematopoietic CELL Transplant Recipients

Author

Arango, Matthew, primary, Weber, Catherine, additional, Neuner, Elizabeth, additional, Cober, Eric, additional, Kalaycio, Matt E., additional, Jagadeesh, Deepa, additional, Pohlman, Brad, additional, Dean, Robert M., additional, Andresen, Steven, additional, Gerds, Aaron, additional, Hanna, Rabi, additional, Abounader, Donna, additional, Flagg, Aron, additional, Bolwell, Brian, additional, Majhail, Navneet S., additional, and Liu, Hien, additional

Published
2016
Full Text
View/download PDF

156. Autologous Stem Cell Transplantation (ASCT) Is Effective Therapy for Older Patients with Non-Hodgkin's Lymphoma (NHL)

Author

Jagadeesh, Deepa, primary, Rybicki, Lisa, additional, Abounader, Donna, additional, Liu, Hein, additional, Dean, Robert M., additional, Hill, Brian T., additional, Sobecks, Ronald M., additional, Gerds, Aaron, additional, Hamilton, Betty Ky, additional, Pohlman, Brad, additional, Kalaycio, Matt E., additional, Bolwell, Brian, additional, and Majhail, Navneet S., additional

Published
2016
Full Text
View/download PDF

157. Graft-Versus-Host Disease-Free, Relapse-Free Survival (GRFS) after Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplant (HCT) in Older Patients with Myeloid Malignancies

Author

Nazha, Aziz, primary, Rybicki, Lisa, additional, Abounader, Donna, additional, Bolwell, Brian, additional, Dean, Robert M., additional, Ferraro, Christina, additional, Gerds, Aaron, additional, Jagadeesh, Deepa, additional, Hamilton, Betty Ky, additional, Hill, Brian T., additional, Kalaycio, Matt E., additional, Liu, Hein, additional, Pohlman, Brad, additional, Sobecks, Ronald M., additional, Starn, Jamie, additional, Winslow, Victoria, additional, Sekeres, Mikkael, additional, and Majhail, Navneet S., additional

Published
2016
Full Text
View/download PDF

158. Durable Long-Term Remission with Allogeneic Hematopoietic Cell Transplantation (HCT) for Relapsed/Refractory Follicular Lymphoma (FL)

Author

Jagadeesh, Deepa, primary, Rybicki, Lisa, additional, Abounader, Donna, additional, Dean, Robert M., additional, Hill, Brian, additional, Liu, Hien, additional, Sobecks, Ronald M., additional, Hamilton, Betty Ky, additional, Gerds, Aaron, additional, Ferraro, Christina, additional, Starn, Jamie, additional, Winslow, Victoria, additional, Pohlman, Brad, additional, Kalaycio, Matt E., additional, Bolwell, Brian, additional, and Majhail, Navneet S., additional

Published
2016
Full Text
View/download PDF

159. Prognostic Value of Pre-Transplant PET Scan in Patients with Diffuse Large B-Cell (DLBCL) Lymphoma Undergoing Autologous Stem Cell Transplantation (ASCT)

Author

Winter, Allison M, primary, Rybicki, Lisa A., additional, Shah, Shetal, additional, Jagadeesh, Deepa, additional, Gerds, Aaron T., additional, Hamilton, Betty K., additional, Liu, Hien, additional, Dean, Robert M., additional, Sobecks, Ronald, additional, Pohlman, Brad, additional, Andresen, Steven, additional, Smith, Mitchell R., additional, Kalaycio, Matt, additional, Bolwell, Brian J., additional, Majhail, Navneet S., additional, and Hill, Brian T., additional

Published
2015
Full Text
View/download PDF

160. Comparative Effectiveness of Fludarabine and Busulfan Versus Fludarabine and 400 cGy Total Body Irradiation Reduced Intensity Conditioning Regimens for Allogeneic Hematopoietic Cell Transplantation for AML/MDS

Author

Mustafa Ali, Moaath, primary, Abounader, Donna M, additional, Rybicki, Lisa A., additional, Yurch, Melissa A, additional, Starn, Jamie, additional, Ferraro, Christina, additional, Winslow, Victoria, additional, Hamilton, Betty K., additional, Gerds, Aaron T., additional, Liu, Hien, additional, Dean, Robert, additional, Hill, Brian T., additional, Pohlman, Brad, additional, Andresen, Steven, additional, Hanna, Rabi, additional, Kalaycio, Matt, additional, Bolwell, Brian J., additional, Majhail, Navneet S., additional, and Sobecks, Ronald, additional

Published
2015
Full Text
View/download PDF

161. Standard Duration of Varicella Zoster Virus Prophylaxis May be Inadequate to Prevent Viral Reactivation in Patients with Chronic Lymphocytic Leukemia Treated with Front-Line Bendamustine Plus Rituximab

Author

Allen, Joshua M., primary, Rybicki, Lisa A., additional, Caimi, Paolo F., additional, Jagadeesh, Deepa, additional, Dean, Robert M., additional, Pohlman, Brad, additional, Smith, Mitchell R., additional, Kalaycio, Matt, additional, and Hill, Brian T., additional

Published
2015
Full Text
View/download PDF

162. Association of Socioeconomic Status (SES) with Outcomes of Autologous Hematopoietic Cell Transplantation (ASCT) for Lymphoma

Author

Hong, Sanghee, primary, Rybicki, Lisa A., additional, Abounader, Donna M, additional, Bolwell, Brian J., additional, Dean, Robert M., additional, Gerds, Aaron T., additional, Hamilton, Betty K., additional, Hill, Brian T., additional, Jagadeesh, Deepa, additional, Kalaycio, Matt, additional, Liu, Hien K., additional, Pohlman, Brad, additional, Sobecks, Ronald, additional, and Majhail, Navneet S., additional

Published
2015
Full Text
View/download PDF

164. Daily Weight-Based Busulfan with Cyclophosphamide and Etoposide (Bu/Cy/VP) Produces Comparable Outcomes to 4-Times-Daily Busulfan Dosing for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation (ASCT)

Author

Hill, Brian T., primary, Rybicki, Lisa A., additional, Weber, Catherine, additional, Jagadeesh, Deepa, additional, Gerds, Aaron T., additional, Hamilton, Betty K., additional, Liu, Hien K., additional, Dean, Robert M., additional, Sobecks, Ronald M., additional, Pohlman, Brad, additional, Andresen, Steven, additional, Kalaycio, Matt, additional, Bolwell, Brian J., additional, and Majhail, Navneet S., additional

Published
2015
Full Text
View/download PDF

165. Reducing Time to Antibiotic Administration for Febrile Neutropenia in the Emergency Department

Author

Keng, Michael K., primary, Thallner, Elaine A., additional, Elson, Paul, additional, Ajon, Christine, additional, Sekeres, Jennifer, additional, Wenzell, Candice M., additional, Seastone, David J., additional, Gallagher, Erika M., additional, Weber, Catherine M., additional, Earl, Marc A., additional, Mukherjee, Sudipto, additional, Pohlman, Brad, additional, Cober, Eric, additional, Foster, Virginia B., additional, Yuhas, Joy, additional, Kalaycio, Matt E., additional, Bolwell, Brian J., additional, and Sekeres, Mikkael A., additional

Published
2015
Full Text
View/download PDF

168. 200 - Impact of MHC Class I Chain-Related Gene a (MICA) Mismatch on Umbilical Cord Blood Hematopoietic Cell Transplantation

Author

Patel, Sagar S., Rybicki, Lisa, Yurch, Melissa, Thomas, Dawn, Jagadeesh, Deepa, Dean, Robert M., Liu, Hein, Flagg, Aron, Cober, Eric, Mossad, Sherif B., Gerds, Aaron T., Hill, Brian T., Hanna, Rabi, Hamilton, Betty K., Pohlman, Brad, Kalaycio, Matt E., Bolwell, Brian, Zhang, Aiwen, Majhail, Navneet S., Askar, Medhat, and Sobecks, Ronald M.

Published
2018
Full Text
View/download PDF

170. 357 - Complication Rates and Resource Utilization in the First 100 Days Following Allogeneic Hematopoietic Cell Transplantation (Allo HCT) Using Related Haploidentical Donors (Haplo) or Umbilical Cord Blood (UCB)

Author

El-Asmar, Jessica, Rybicki, Lisa, Bernhard, Laura, Coffman, Julie, Corrigan, Donna, Dean, Robert M., Gerds, Aaron T., Hamilton, Betty K., Hill, Brian T., Jagadeesh, Deepa, Kalaycio, Matt E., Liu, Hien, Pohlman, Brad, Serafino, Sheila, Urban, Theresa A., Sobecks, Ronald M., and Majhail, Navneet S.

Published
2018
Full Text
View/download PDF

171. Neutropenic fever during peripheral blood progenitor cell mobilization is associated with decreased CD34+ cell collection and increased apheresis collection days.

Author

Khouri, Jack, Rybicki, Lisa, Majhail, Navneet, Kalaycio, Matt, Copelan, Edward, Pohlman, Brad, Hill, Brian, Dean, Robert, Lazaryan, Aleksandr, Hamilton, Betty, Andresen, Steven, Sobecks, Ronald, Bolwell, Brian, and Liu, Hien

Abstract

Abstract: Background: Peripheral blood progenitor cell (PBPC) mobilization with chemotherapy in addition to Granulocyte‐Colony Stimulating Factor (G‐CSF) improves cell collection compared to G‐CSF alone; however, it is associated with increased risk of neutropenic fever (NF). Methods: We analyzed risk factors for post‐priming NF and NF association with autologous stem cell transplant outcomes. Between 1998 and 2008, 593 adult patients with lymphoma underwent PBPC mobilization with etoposide and G‐CSF. Results: Median age was 51 years (range 18–77) and 372 (63%) were male. Diagnoses were 457 (77%) non‐Hodgkin lymphoma and 136 (23%) Hodgkin lymphoma. Of 554 (93%) transplanted patients, majority were in complete or partial remission at time of transplant (88%). Overall, 141 (24%) patients were hospitalized for NF. Nine patients (6%) had bacteremia, 4 (3%) had pneumonia, 2 (<1%) had herpes simplex viral infections, and the remaining 126 (90%) had no identified infection source. NF patients had lower likelihood of proceeding to transplant (86% vs. 96%, P < .001), lower CD34+ cell dose collection (median 7.23 × 106 CD34+ cells/kg vs. 8.98 × 106 CD34+ cells/kg, P = .002), and were more likely to require > 4 days of apheresis (48% vs. 37%, P < .001). NF was associated with a higher 30‐day readmission rate following transplant hospitalization (17% vs. 9%, P = .012). Conclusion: NF during etoposide priming is associated with lower likelihood of proceeding to transplant, lower CD34+ cell dose collection, more apheresis days required for collection and a higher 30‐day readmission rate following transplant discharge. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

172. Prognostic value of pre-transplant PET/CT in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation.

Author

Winter, Allison, Jagadeesh, Deepa, Gerds, Aaron T., Hamilton, Betty K., Liu, Hien, Dean, Robert, Sobecks, Ronald, Pohlman, Brad, Kalaycio, Matt, Bolwell, Brian J., Majhail, Navneet S., Hill, Brian T., Smith, Mitchell, Rybicki, Lisa, and Shah, Shetal N.

Subjects
BCL-2 proteins, STEM cell transplantation, PROGRESSION-free survival, POSITRON emission tomography, LYMPHOMAS
Abstract

Pre-transplant PET/CT may be prognostic in diffuse large B-cell lymphoma (DLBCL) patients undergoing autologous stem cell transplantation (ASCT). We reviewed relapsed and pre-transplant PET/CT scans of 32 patients with DLBCL treated with ASCT to determine the Deauville score and the maximum standardized uptake value (SUVmax). Patients with a Deauville score of 4 had a significantly inferior prognosis. The 3-year progression-free survival (PFS) for patients with Deauville 1-3 score was 64%, compared to 0% for Deauville 4, while the 3-year overall survival (OS) was 84% and 25%, respectively (p < .001, p = .002). The change in the SUVmax (>66 versus ≤66%) was not predictive of PFS or OS, but a high pre-transplant SUVmax (>6) demonstrated a trend towards an inferior PFS. Pre-transplant PET/CT is a tool for identifying DLBCL patients at high risk for treatment failure with ASCT and could be used to risk-stratify patients in prospective clinical trials of novel transplant strategies. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

173. A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphoma.

Author

Hill, Brian T., Smith, Mitchell R., Shelley, Meredeth, Jagadeesh, Deepa, Dean, Robert M., Pohlman, Brad, Sweetenham, John W., Bolwell, Brian J., and Smith, Stephen D.

Subjects
HODGKIN'S disease treatment, LYMPHOBLASTIC leukemia treatment, HEMATOPOIETIC system, IMMUNOLOGIC diseases, T-cell lymphoma
Abstract

B-cell non-Hodgkin lymphomas (NHL) display dysregulation of pathways controlling cell proliferation and apoptosis. Combined proteasome and mTOR inhibition, demonstrated with bortezomib and everolimus in a preclinical model, thus warrants evaluation in humans. We conducted a phase I study to identify the maximum tolerated dose (MTD) and safety of this combination in relapsed/refractory (r/r) NHL. Twenty-nine patients were enrolled from July 2008 to March, 2015. Toxicities were primarily hematologic, and dose-limiting thrombocytopenia defined the MTD as 5mg everolimus daily with 1.3 mg/m² bortezomib d1, 4, 8, and 11 every 21 days. Of 25 response-evaluable patients there was one complete response in a patient with MCL and three partial responses (two MCL, one FL) for an overall response rate of 16%. In conclusion, the combination of everolimus and bortezomib results in dose limiting thrombocytopenia, but is tolerable. This combination has limited clinical activity in heavily pretreated NHL. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

174. Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL).

Author

Sanikommu, Srinivasa R., Clemente, Michael J., Chomczynski, Peter, Afable II, Manuel G., Jerez, Andres, Thota, Swapna, Patel, Bhumika, Hirsch, Cassandra, Nazha, Aziz, Desamito, John, Lichtin, Alan, Pohlman, Brad, Sekeres, Mikkael A., Radivoyevitch, Tomas, and Maciejewski, Jaroslaw P.

Subjects
LYMPHOCYTIC leukemia, KILLER cells, GENETIC mutation, CLINICAL trials, CANCER patients
Abstract

Large granular lymphocytic leukemia (LGLL) represents a clonal/oligoclonal lymphoproliferation of cytotoxic T and natural killer cells often associated withSTAT3mutations. When symptomatic, due to mostly anemia and neutropenia, therapy choices are often empirically-based, because only few clinical trials and systematic studies have been performed. Incorporating new molecular and flow cytometry parameters, we identified 204 patients fulfilling uniform criteria for LGLL diagnoses and analyzed clinical course with median follow-up of 36 months, including responses to treatments. While selection of initial treatment was dictated by clinical features, the initial responses, as well as overall responses to methotrexate (MTX), cyclosporine (CsA), and cyclophosphamide (CTX), were similar at 40–50% across drugs. Sequential use of these drugs resulted in responses in most cases: only 10–20% required salvage therapies such as ATG, Campath, tofacitinib, splenectomy or abatacept. MTX yielded the most durable responses.STAT3-mutated patients required therapy more frequently and had better overall survival. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

175. Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantation

Author

Patel, Sagar S., Rybicki, Lisa A., Corrigan, Donna, Dumont, Carol, Bolwell, Brian, Dean, Robert, Figueroa, Priscilla, Hanna, Rabi, Liu, Hien, Gerds, Aaron T., Hill, Brian, Jagadeesh, Deepa, Kalaycio, Matt, Pohlman, Brad, Ricci, Kristin, Sobecks, Ronald, Lu, Wen, Hamilton, Betty K., and Majhail, Navneet S.

Abstract

Donor-derived T-cells mediate graft-versus-leukemia effect, immune reconstitution, and graft-versus-host-disease (GvHD) after allogeneic hematopoietic cell transplantation (HCT). We examined the association of donor cell subsets with outcomes in recipients of myeloablative allogeneic HCT using bone marrow (BM, N= 359) grafts from 2002 to 2014 with related or unrelated donors. Analysis considered pre-infusion graft total nucleated cell (TNC), CD34+ CD3+, CD4+, CD8+ doses. Most patients received busulfan-cyclophosphamide or etoposide-total body irradiation conditioning for acute leukemia or myelodysplastic syndrome. Calcineurin inhibitor-mycophenolate mofetil (CNI-MMF) (49%) or calcineurin inhibitor-methotrexate (CNI-MTX) (47%) were used for GvHD prophylaxis. In multivariable analysis, higher CD34+ dose was associated with platelet engraftment (P< 0.001) and lymphocyte recovery (P= 0.006). There was no association of donor cell subsets with donor chimerism or overall survival. In conclusion, BM graft composition is associated with myeloablative allogeneic HCT outcomes and future studies to evaluate optimal graft composition are needed.

Published
2019
Full Text
View/download PDF

177. Predictors for Recurrent 30-Day Unplanned Readmissions in Patients with Hematologic Malignancies

Author

Kunapareddy, Girish, Ahmed, Hina, Patel, Sagar S., Patel, Bhumika J., Elson, Paul, Bitterice, Alicia, Gerds, Aaron T., Carraway, Hetty E., Advani, Anjali S., Nazha, Aziz, Montero, Alberto J., Pohlman, Brad, Strazalka, Colleen, Hooley, Joseph, Redden, Alicia, Tullio, Katherine, Bell, Kimberly, Kalaycio, Matt, Sekeres, Mikkael A., and Mukherjee, Sudipto

Published
2017
Full Text
View/download PDF

180. Outcomes and prognostic factors in marginal zone lymphoma: Case comprehensive cancer center cumulative experience of 358 cases.

Author

Starr, Adam, primary, Fu, PingFu, additional, Caimi, Paolo Fabrizio, additional, Campagnaro, Erica Leigh, additional, Cooper, Brenda W., additional, De Lima, Marcos J.G., additional, Lazarus, Hillard M., additional, Gerson, Stanton L., additional, Meyerson, Howard, additional, Jagadeesh, Deepa, additional, Smith, Mitchell Reed, additional, Dean, Robert M., additional, Pohlman, Brad L., additional, Hill, Brian Thomas, additional, and William, Basem M., additional

Published
2015
Full Text
View/download PDF

181. Bortezomib-Based Induction Therapy PRIOR to High Dose Melphalan and Autologous Hematopoietic CELL Transplantation in Primary Amyloidosis

Author

Duong, Hien K., primary, Rybicki, Lisa, additional, Abounader, Donna, additional, Bolwell, Brian, additional, Kalaycio, Matt E., additional, Valent, Jason, additional, Samaras, Christy, additional, Reu, Fred, additional, Sobecks, Ronald, additional, Jagadeesh, Deepa, additional, Hamilton, Betty, additional, Andresen, Steven, additional, Gerds, Aaron, additional, Hanna, Rabi, additional, Pohlman, Brad, additional, and Majhail, Navneet S., additional

Published
2015
Full Text
View/download PDF

182. The Impact of Histologic Grade on Acute Graft Versus Host Disease Response and Outcomes

Author

Narkhede, Mayur, primary, Rybicki, Lisa, additional, Abounader, Donna, additional, Andresen, Steven, additional, Bolwell, Brian, additional, Dean, Robert M., additional, Duong, Hien K., additional, Gerds, Aaron, additional, Hanna, Rabi, additional, Hill, Brian, additional, Jagadeesh, Deepa, additional, Kalaycio, Matt E., additional, Pohlman, Brad, additional, Sobecks, Ronald, additional, Majhail, Navneet S., additional, and Hamilton, Betty Ky, additional

Published
2015
Full Text
View/download PDF

183. Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT)

Author

Askar, Medhat, primary, Majhail, Navneet S., additional, Rybicki, Lisa, additional, Zhang, Aiwen, additional, Thomas, Dawn, additional, Chen, Dongxing, additional, Abounader, Donna, additional, Bolwell, Brian, additional, Dean, Robert M., additional, Duong, Hien K., additional, Gerds, Aaron, additional, Hamilton, Betty, additional, Hanna, Rabi, additional, Hill, Brian, additional, Jagadeesh, Deepa, additional, Pohlman, Brad, additional, Kalaycio, Matt E., additional, Sayer, David, additional, and Sobecks, Ronald, additional

Published
2015
Full Text
View/download PDF

184. Socioeconomic Status Influences Long-Term Outcomes in 1-Year Survivors after Allogeneic Hematopoietic Cell Transplantation

Author

Fu, Shuang, primary, Rybicki, Lisa, additional, Abounader, Donna, additional, Andresen, Steven, additional, Bolwell, Brian, additional, Dean, Robert M., additional, Duong, Hien K., additional, Gerds, Aaron, additional, Hamilton, Betty Ky, additional, Hanna, Rabi, additional, Hill, Brian, additional, Jagadeesh, Deepa, additional, Kalaycio, Matt E., additional, Pohlman, Brad, additional, Sobecks, Ronald, additional, and Majhail, Navneet S., additional

Published
2015
Full Text
View/download PDF

185. Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Cellular Infusion for Relapse after Transplant

Author

Hamilton, Betty Ky, primary, Mani, Shylaja, additional, Rybicki, Lisa, additional, Abounader, Donna, additional, Andresen, Steven, additional, Bolwell, Brian, additional, Dean, Robert M., additional, Duong, Hien K., additional, Gerds, Aaron, additional, Hanna, Rabi, additional, Hill, Brian, additional, Jagadeesh, Deepa, additional, Kalaycio, Matt E., additional, Pohlman, Brad, additional, Sobecks, Ronald, additional, and Majhail, Navneet S., additional

Published
2015
Full Text
View/download PDF

187. Autologous Stem Cell Transplantation for Follicular Lymphoma in the Era of Rutiximab: Cleveland Clinic Experience

Author

Jagadeesh, Deepa, primary, Rybicki, Lisa, additional, Abounader, Donna M, additional, Hill, Brian T., additional, Dean, Robert M, additional, Duong, Hien K., additional, Sobecks, Ronald M., additional, Hamilton, Betty K., additional, Gerds, Aaron, additional, Ferraro, Christina, additional, Green, Gina, additional, Cherni, Kelly, additional, Pohlman, Brad, additional, Kalaycio, Matt E., additional, Bolwell, Brian J., additional, and Majhail, Navneet S., additional

Published
2014
Full Text
View/download PDF

189. Efficacy of Standard Dose R-CHOP Alternating with R-HiDAC Followed By ASCT As Initial Therapy of Mantle Cell Lymphoma: Cleveland Clinic Experience

Author

Sun, Danyu, primary, Hill, Brian T., additional, Rybicki, Lisa, additional, Rouphail, Basel, additional, Dean, Robert M, additional, Jagadeesh, Deepa, additional, Gerds, Aaron T., additional, Hamilton, Betty K., additional, Sobecks, Ronald M., additional, Duong, Hien K., additional, Andresen, Steven, additional, Majhail, Navneet S., additional, Pohlman, Brad, additional, Kalaycio, Matt E., additional, Bolwell, Brian J., additional, and Smith, Mitchell R., additional

Published
2014
Full Text
View/download PDF

190. Prognostic Significance of Quality of Life in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Author

Hamilton, Betty K., primary, Rybicki, Lisa, additional, Abounader, Donna M, additional, Dabney, Jane, additional, Dean, Robert M, additional, Duong, Hien K., additional, Hill, Brian T., additional, Gerds, Aaron, additional, Jagadeesh, Deepa, additional, Kalaycio, Matt E., additional, Lawrence, Christine, additional, McLellan, Linda, additional, Pohlman, Brad, additional, Sobecks, Ronald M., additional, Bolwell, Brian J., additional, and Majhail, Navneet S., additional

Published
2014
Full Text
View/download PDF

192. Comparison of Burkitt Lymphoma (BL) and B-Cell Lymphoma, Unclassifiable with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma (BCL-U) Patient Outcomes: Intensive Therapy May Not Benefit BCL-U

Author

Bumma, Naresh, primary, Rybicki, Lisa, additional, Caimi, Paolo, additional, Jagadeesh, Deepa, additional, Dean, Robert M, additional, Pohlman, Brad, additional, Smith, Mitchell R., additional, and Hill, Brian T., additional

Published
2014
Full Text
View/download PDF

193. Long Term Outcomes after Autologous Stem Cell Transplantation for Peripheral T Cell Lymphomas

Author

Jagadeesh, Deepa, primary, Rybicki, Lisa, additional, Abounader, Donna M, additional, Hill, Brian T., additional, Dean, Robert M, additional, Duong, Hien K., additional, Sobecks, Ronald M., additional, Hamilton, Betty K., additional, Gerds, Aaron, additional, Ferraro, Christina, additional, Green, Gina, additional, Cherni, Kelly, additional, Pohlman, Brad, additional, Kalaycio, Matt E., additional, Bolwell, Brian J., additional, and Majhail, Navneet S., additional

Published
2014
Full Text
View/download PDF

194. A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma

Author

Foss, Francine, primary, Advani, Ranjana, additional, Duvic, Madeleine, additional, Hymes, Kenneth B., additional, Intragumtornchai, Tanin, additional, Lekhakula, Arnuparp, additional, Shpilberg, Ofer, additional, Lerner, Adam, additional, Belt, Robert J., additional, Jacobsen, Eric D., additional, Laurent, Guy, additional, Ben-Yehuda, Dina, additional, Beylot-Barry, Marie, additional, Hillen, Uwe, additional, Knoblauch, Poul, additional, Bhat, Gajanan, additional, Chawla, Shanta, additional, Allen, Lee F., additional, and Pohlman, Brad, additional

Published
2014
Full Text
View/download PDF

196. The Role of Corrected Dlco in Predicting Relapse and Mortality Post Autologous Hematopoietic Cell Transplantation in Multiple Myeloma

Author

Awada, Hussein, Hajj Ali, Adel, Ali, Muhammad Faizan, Mazzoni, Sandra, Faiman, Beth M., Jagadeesh, Deepa, Williams, Louis S., Winter, Allison, Samaras, Christy J., Sauter, Craig S., van Heeckeren, Willem J., Dean, Robert M., Pohlman, Brad, Hill, Brian T., Valent, Jason, Sobecks, Ronald M., Hamilton, Betty K., Kalaycio, Matt, Anwer, Faiz, and Khouri, Jack

Published
2022
Full Text
View/download PDF

197. Long-Term Outcomes of Autologous Hematopoietic Cell Transplant of Multiple Myeloma: A 10 Year Follow up Study

Author

Awada, Hussein, Hajj Ali, Adel, Ali, Muhammad Faizan, Faiman, Beth M., Winter, Allison, Mazzoni, Sandra, Jagadeesh, Deepa, Samaras, Christy J., Williams, Louis S., Sauter, Craig S., van Heeckeren, Willem J., Dean, Robert M., Pohlman, Brad, Hamilton, Betty K., Hill, Brian T., Valent, Jason, Sobecks, Ronald M., Kalaycio, Matt, Khouri, Jack, and Anwer, Faiz

Published
2022
Full Text
View/download PDF

198. Long-Term Outcomes of Delayed Neutrophil Engraftment Following Autologous Hematopoietic Cell Transplant in Multiple Myeloma

Author

Awada, Hussein, Hajj Ali, Adel, Faiman, Beth M., Winter, Allison, Mazzoni, Sandra, Samaras, Christy J., Sauter, Craig S., van Heeckeren, Willem J., Dean, Robert M., Pohlman, Brad, Hill, Brian T., Valent, Jason, Sobecks, Ronald M., Williams, Louis S., Jagadeesh, Deepa, Hamilton, Betty K., Kalaycio, Matt, Khouri, Jack, and Anwer, Faiz

Published
2022
Full Text
View/download PDF

199. Risk of Venous Thromboembolism in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplant

Author

Awada, Hussein, Hajj Ali, Adel, Faiman, Beth M., Winter, Allison, Mazzoni, Sandra, Samaras, Christy J., Sauter, Craig S., van Heeckeren, Willem J., Dean, Robert M., Pohlman, Brad, Hill, Brian T., Valent, Jason, Sobecks, Ronald M., Williams, Louis S., Jagadeesh, Deepa, Hamilton, Betty K., Kalaycio, Matt, Anwer, Faiz, and Khouri, Jack

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results